Topics

Vista Equity Partners Company Profile

07:38 EDT 21st September 2019 | BioPortfolio

Vista Equity Partners, a U.S.-based investment firm with offices in Austin, San Francisco, Chicago, and Oakland with more than $31 billion in cumulative capital commitments, currently invests in software, data and technology-enabled organizations led by world-class management teams with long-term perspective. Vista is a value-added investor, contributing professional expertise and multi-level support towards companies realizing their full potential. Vista’s investment approach is anchored by a sizable long-term capital base, experience in structuring technology-oriented transactions, and proven management techniques that yield flexibility and opportunity in private equity investing. For more information, please visit www.vistaequitypartners.com.


News Articles [603 Associated News Articles listed on BioPortfolio]

Vista's Cloud Chase Scores $2 Billion Deal

Private equity firm Vista Equity Partners, helmed by Robert F. Smith just banked about £2 billion ($2.4 billion) as they look to share the risk of growing cloud based companies. The deal is with BC P...

Jaybird Vista Review: Sporty Earbuds Worth a Listen | WIRED – WIRED

Jaybird Vista Review: Sporty Earbuds Worth a Listen | WIRED WIREDJaybird's Vista earbuds overcome the company's true wireless problems Circuit BreakerJaybird's Vista are a sleeker pair of wirel...

Monroe Capital Supports Vista Equity Partners’ Acquisition of MINDBODY, Inc.

Monroe Capital LLC today announced it acted as co-lead arranger on the funding of a senior credit facility to support the growth of MINDBODY, Inc. (NASDAQ: MB) (“Mindbody”) by...

Great Point Partners Makes $22 Million Equity Commitment to Bionova Scientific

GREENWICH, Conn. and FREMONT, Calif. (PRWEB) June 03, 2019 Great Point Partners (“GPP”), a Greenwich-based private investm...

Private equity firm Francisco Partners acquires Qualcomm Life

Qualcomm Life will be renamed as Capsule Technologies and will continue to operate its two business segments, Capsule, a provider of medical device connectivity solutions for hospitals, and The post ...

Private equity companies acquire virtual research firm Thread

Financial terms of the deal were not disclosed. However, Thread said it would use the investment – from JLL Partners and Water Street Healthcare Partners – to accelerate the expansion of i...

New VC Firm Blueprint Equity Puts $6M into Florida Software Company

A new venture capital firm, which in November marked its launch by raising a $53 million-plus fund to invest in startups, has made its first investment. Blueprint Equity managing partners Sheldon Lewi...

DMC Biotechnologies, Inc. Announces First Close of $10.3M Series A Financing Led by Sofinnova Partners

[Boulder, CO] July 9, 2019 – DMC (www.dmcbio.com), an early-stage biotechnology company, announced today that is has raised a Series A equity financing led by Sofinnova Partners. The company also an...

PubMed Articles [394 Associated PubMed Articles listed on BioPortfolio]

Structure and Functional Binding Epitope of V-domain Ig Suppressor of T Cell Activation.

V-domain immunoglobulin (Ig) suppressor of T cell activation (VISTA) is an immune checkpoint protein that inhibits the T cell response against cancer. Similar to PD-1 and CTLA-4, a blockade of VISTA...

Gendered perceptions of fairness in housework and shared expenses: Implications for relationship satisfaction and sex frequency.

There is a demonstrated relationship between couples' division of household chores-and, to a lesser extent, the division of shared expenses-and their relationship quality. Less is known, however, abou...

PD-L1, B7-H3 and VISTA are highly expressed in gestational trophoblastic neoplasia.

The B7 family checkpoint molecules are potential therapeutic targets in cancer immunotherapy. However, their expression status in human gestational trophoblastic neoplasia (GTN) remains unknown. We in...

Periprocedural safety and technical outcomes of the new Silk Vista Baby flow diverter for the treatment of intracranial aneurysms: results from a multicenter experience.

The aim of our study was to assess the technical success and the safety of this new low-profile flow diverter Silk Vista Baby (SVB) by evaluating the intraprocedural and periprocedural complication ra...

The effects of tech and non-tech innovation on brand equity in China: The role of institutional environments.

Recently, innovation has been a key driver of brand equity. However, the emerging economies provide a dynamic institutional environment that makes it difficult to explore the relationship between inno...

Clinical Trials [466 Associated Clinical Trials listed on BioPortfolio]

Patient Satisfaction After Root Coverage Using VISTA Technique Compared to MCAF Technique With PRF.

VISTA technique with PRF compared to MCAF technique with PRF to treat gingival recession

Safety and Efficacy of Silk Vista Baby Flow Diverter for Intracranial Aneurysm Treatment

The FIRST study is an observational, prospective, multi-center, international, single-arm, study. The aim of the study is to collect safety and efficacy information on the use of the silk ...

Evaluation of Link for Equity (Students of Color Population)

The investigators propose to develop and evaluate Link for Equity, a trauma-informed system of care. Link, a system of support for ACE-affected children, is composed of universal school Tr...

Evaluation of Esthetic Root Coverage Using Platelet-Rich Fibrin Versus Subepithelial Connective Tissue Graft With Vestibular Incision Subperiosteal Tunnel Access in Multiple Gingival Recessions

Patients with gingival recession, complain of excessive tooth length that affects their appearance during smiling or functioning. The main goal of plastic periodontal surgeries is to resto...

Evaluation of Link for Equity (School Staff Population)

The investigators propose to develop and evaluate Link for Equity, a trauma-informed system of care. Link, a system of support for ACE-affected children, is composed of universal school Tr...

Companies [1473 Associated Companies listed on BioPortfolio]

Vista Partners

With offices in California and Oregon, Vista Partners LLC is one of the fastest growing independently owned equity research and consulting firms in the United States. Vista Partners professional staff...

Vista Partners LLC

Vista Partners LLC was founded in 2005 and has offices in California and Oregon. Vista is one of the fastest growing independently owned equity research and consulting firms in the United States. Vist...

Vista Equity Partners

Vista Equity Partners, a U.S.-based investment firm with offices in Austin, San Francisco, Chicago, and Oakland with more than $31 billion in cumulative capital commitments, curre...

New Vista Behavioral Health

New Vista Behavioral Health’s mission is to provide innovative, client-centered, evidence-based, treatment solutions to create a healthy and productive new vista for recovery...

Great Hill Equity Partners IV, L.P. and certain of its affiliates

Great Hill Partners is an investment firm that manages over $2.7 billion in capital and focuses on investing in growth companies operating in the business and consumer services, media, transaction pro...

More Information about "Vista Equity Partners" on BioPortfolio

We have published hundreds of Vista Equity Partners news stories on BioPortfolio along with dozens of Vista Equity Partners Clinical Trials and PubMed Articles about Vista Equity Partners for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Vista Equity Partners Companies in our database. You can also find out about relevant Vista Equity Partners Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks



Searches Linking to this Company Record